Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial

• मुख्य लेखकों: Himanshu P. Upadhyaya (लेखक), Lesley M. Arnold (लेखक), Karla Alaka (लेखक), Meihua Qiao (लेखक), David Williams (लेखक), Renata Mehta (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: BMC, 2019-05-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Currently, there are no medications approved for the treatment of juvenile fibromyalgia (JFM). We evaluated the safety and efficacy of duloxetine 30/60 mg once daily (QD) versus placebo in adolescents with JFM. Methods In this Phase 3b, multisite (US, Argentina, Puerto Rico, and...